[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337485-105":59,"doc-detail-337485-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","unraveling-the-potential-of-cd8-cd68-and-vista-as-diagnostic-and-prognostic-markers-in-patients-with-pancreatic-ductal-adenocarcinoma","Unraveling the potential of CD8, CD68, and VISTA as diagnostic and prognostic markers in patients with pancreatic ductal adenocarcinoma","","Pancreatic cancer remains a highly aggressive disease with limited treatment options and poor outcomes. Immunotherapy shows benefit in several cancers, yet pancreatic ductal adenocarcinoma (PDAC) has not benefited consistently, making reliable immunology-related biomarkers essential. This study evaluates the diagnostic and prognostic value of CD8, CD68, and VISTA using GEO-based bioinformatics, protein–protein interaction and transcription factor analyses, and immunohistochemistry validation in PDAC and normal tissues, followed by clinicopathologic correlation and survival assessment.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/unraveling-the-potential-of-cd8-cd68-and-vista-as-diagnostic-and-prognostic-markers-in-patients-with-pancreatic-ductal-adenocarcinoma/337485/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/unraveling-the-potential-of-cd8-cd68-and-vista-as-diagnostic-and-prognostic-markers-in-patients-with-pancreatic-ductal-adenocarcinoma/337485.png","ImageObject",300,407,{"name":92,"@type":93},"Patrick","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-14","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the main goal of this study?","Question",{"text":113,"@type":114},"To assess the diagnostic and prognostic significance of CD8, CD68, and VISTA in pancreatic ductal adenocarcinoma (PDAC).","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were CD8, CD68, and VISTA evaluated?",{"text":118,"@type":114},"The study used GEO gene-expression bioinformatics, STRING and Funrich for interaction and transcription-factor analysis, and immunohistochemistry on PDAC and normal pancreatic tissue samples.",{"name":120,"@type":111,"acceptedAnswer":121},"What relationships were found between marker expression and clinical outcomes?",{"text":122,"@type":114},"VISTA and CD68 showed higher expression in PDAC, while CD8A was reduced. Survival analysis indicated that high CD8 expression was associated with better disease-specific survival and progression-free survival.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},337485,1790182245,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","TYPE Original Research PUBLISHED 30 January 2024  \nDOI 10.3389/fimmu.2024.1283364  \nOPEN ACCESS  \nEDITED BY  \nFrancesco Sabbatino, University of Salerno, Italy  \nREVIEWED BY  \nTheodoros Michelakos,  \nHarvard Medical School, United States Evangelos Koustas,  \nNational and Kapodistrian University of Athens, Greece  \n*CORRESPONDENCE Elahe Safari  \n [Safari.e@iums.ac.ir](Safari.e@iums.ac.ir);  \n [El.safari@yahoo.com](El.safari@yahoo.com)[ ](El.safari@yahoo.com)Mohammad Taghi Joghataei  \n [Mt.joghataei@yahoo.com](Mt.joghataei@yahoo.com);  \n [Joghataei.mt@iums.ac.ir](Joghataei.mt@iums.ac.ir)  \n†These authors have contributed equally to this work  \nRECEIVED 25 August 2023  \nACCEPTED 15 January 2024  \nPUBLISHED 30 January 2024  \nCITATION  \nRezagholizadeh F, Tajik F, Talebi M, Taha SR, Shariat Zadeh M, Farhangnia P, Hosseini HS, Nazari A, Mollazadeh Ghomi S,  \nKamrani Mousavi SM, Haeri Moghaddam N, Khorramdelazad H, Joghataei MT and Safari E (2024) Unraveling the potential of CD8, CD68, and VISTA as diagnostic and prognostic markers in patients with pancreatic ductal adenocarcinoma.  \nFront. Immunol. 15:1283364 .  \ndoi: 10.3389/fimmu.2024.1283364  \nCOPYRIGHT  \n© 2024 Rezagholizadeh, Tajik, Talebi, Taha, Shariat Zadeh, Farhangnia, Hosseini, Nazari, Mollazadeh Ghomi, Kamrani Mousavi,  \nHaeri Moghaddam, Khorramdelazad, Joghataei and Safari. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nUnraveling the potential of CD8, CD68, and VISTA as diagnostic and prognostic markers inpatients with pancreatic ductal adenocarcinoma  \nFereshteh Rezagholizadeh 1,2,3, Fatemeh Tajik 4,  \nMorteza Talebi 1,5,6, Seyed Reza Taha 4†, Mahdieh Shariat Zadeh 4†, Pooya Farhangnia 3,7,8†, Hamideh Sadat Hosseini 1,  \nAram Nazari 1,9, Shabnam Mollazadeh Ghomi 1,7,9, Seyede Mahtab Kamrani Mousavi 1,10,  \nNiloofar Haeri Moghaddam 1,10, Hossein Khorramdelazad 3,11, Mohammad Taghi Joghataei 1,2* and Elahe Safari 3,8*  \n1Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran,  \n2 Department of Molecular Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran, 3 Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran, 4Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran, 5 Department of Medical Genetics and Molecular Biology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran, 6 Human and Animal Cell Bank, Iranian Biological Resource Center (IBRC), Tehran, Iran, 7 Immunology Board for Transplantation and Cell-Based Therapeutics (ImmunoTACT), Universal Scientiﬁc Education and Research Network (USERN), Tehran, Iran, 8 Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran, 9 Department of Pathology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran, 10 Department of Medical Nanotechnology, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran, 11 Department of Immunology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran  \nIntroduction: Pancreatic cancer is a truculent disease with limited treatment options and a grim prognosis. Immunotherapy has shown promise in treating various types of cancer, but its effectiveness in pancreatic cancer has been lacking. As a result, it is crucial to identify markers associated with immunological pathways in order to improve the treatment outcomes for this deadly cancer. The purpose of this study was to investiga","cbCairwDMQQTh1xX","https://ap.wps.com/l/cbCairwDMQQTh1xX","pdf",14903332,21,"English","# Introduction\n# Methods\n# Results\n# Conclusion","[{\"question\":\"What was the main goal of this study?\",\"answer\":\"To assess the diagnostic and prognostic significance of CD8, CD68, and VISTA in pancreatic ductal adenocarcinoma (PDAC).\"},{\"question\":\"How were CD8, CD68, and VISTA evaluated?\",\"answer\":\"The study used GEO gene-expression bioinformatics, STRING and Funrich for interaction and transcription-factor analysis, and immunohistochemistry on PDAC and normal pancreatic tissue samples.\"},{\"question\":\"What relationships were found between marker expression and clinical outcomes?\",\"answer\":\"VISTA and CD68 showed higher expression in PDAC, while CD8A was reduced. Survival analysis indicated that high CD8 expression was associated with better disease-specific survival and progression-free survival.\"}]","Unraveling the potential of CD8, CD68, and VISTA as diagnostic and prognostic markers in patients with pancreatic ductal adenocarcinoma | PDF",1790019316,53,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/24334dc2796f4f9bc843f15ac84fae8a.webp",983,1389,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/40cf938f74c6d233be684f4e147666a7.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/909fc43eb1bff23b060ffb2cf6ff208b.webp",981,1386,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/955f0101643c36162dd423c0470d091a.webp",980,1385]